Body dysmorphic disorder

LAST UPDATED: Jan 18, 2021

Introduction

Body dysmorphic disorder (BDD) is characterised by a preoccupation with a real or an imagined defect in physical appearance, with a level of concern that is out of proportion to the perceived anomaly.

This chapter is set out as follows:


History

  • The incidence of body dysmorphic disorder BDD is 1–2%, and increasing, probably as a result of social media
  • It is more common in patients seeking aesthetic and cosmetic surgery, and there is a high degree of co‐morbidity with mood disorders, OCD and social phobia
  • The female to male ratio is approximately 2:1 but the gap is narrowing
  • BDD often starts in adolescence but may affect any age group

Clinical findings

  • Facial and hair symptoms are common
     
  • Patients may present with symptoms according to their gender:
    • Women may focus on the skin of the face, the breasts, nose and stomach
    • Men may present with concerns about hair (usually thinning), nose, ears, genitals and body build
       
  • Patients will show some of the following traits:
    • Take many photographs of themselves on their phone
    • Feel uncomfortable looking in mirrors
    • Have very persistent and intrusive thoughts about their perceived ’defect’
    • Hide their 'defect'
    • Socialize poorly
    • Pick at their skin
    • Repeatedly seek help from different health care professionals, including cosmetic surgeons

Management

  • From the outset it is important to treat the psychological disease whilst addressing the perceived skin anomaly - it is essential that all health professionals recognise the skin changes, however minimal, rather than dismissing them
     
  • The level of psychological input needed will vary depending on the severity of symptoms, and can include:
    • Counselling
    • Cognitive behavioural therapy
    • Medication - selective serotonin reuptake inhibitors. Higher dosing regimens than those used for depression are usually required. Patients should receive a trial of 3 months before efficacy is assessed
       
  • Surgery should be avoided if at all possible as often it will fail to meet the patient's expectations
     
  • The prognosis for patients with BDD is variable, but good, when treated by dedicated BDD teams. Younger patients may have a better prognosis, in that relative dissatisfaction with appearance may be a relatively normal experience in this age group and may be self‐limiting

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco